Thursday, November 5, 2026

Silver Futures Is 13% Down In The Last 21 Sessions

Silver Futures Is 13% Down In The Last 21 Sessions

(VIANEWS) - Silver (SI) has been up by 13.14% for the last 21 sessions. At 20:51 EST on Wednesday, 7 August, Silver (SI) is $26.77.

Volume

Today's last reported volume for Silver is 2167, 99.99% below its average volume of 9041546393.05.

Volatility

Silver's last week, last month's, and last quarter's current intraday variation average was 1.24%, 0.75%, and 1.40%, respectively.

Silver's highest amplitude of average volatility was 1.24% (last week), 1.17% (last month), and 1.40% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Silver's commodity is considered to be oversold (<=20).

Previous days news about Silver (SI)

  • Silver price forecast: xag/usd remains tepid near $27.00 due to diminished safe-haven appeal. According to FXStreet on Tuesday, 6 August, "However, the downside of non-yielding metals like Silver could be restrained due to the expectation of a 50-basis point (bps) interest rate cut by the US Federal Reserve (Fed) in September. "
  • Silver price forecast: xag/usd declines below $27 as demand concerns escalate. According to FXStreet on Tuesday, 6 August, "On the downside, the horizontal line plotted from May 2 low near $26.00 will bekey support for the Silver price bulls.", "Meanwhile, higher bond yields and a decent recovery in the US Dollar (USD) have also weighed on the Silver price. "

News about

  • According to FXStreet on Wednesday, 7 August, "The American Petroleum Institute (API) reported an increase of 0.18 million barrels in the Weekly Crude Oil Stock for the week ending August 2, falling short of the expected 0.85 million barrels. ", "Additionally, the US Energy Information Administration is set to release its Crude Oil Stocks Change report later in the North American session."
  • According to FXStreet on Tuesday, 6 August, "This is expected to dent fuel demand and drags Crude Oil prices lower for the fourth straight day, which, in turn, is seen undermining demand for the commodity-linked Loonie. ", "Furthermore, the risk of a broader Middle East conflict continues to fuel concerns about supply disruptions from the key Oil producing region and could help limit losses for Crude Oil prices. "
  • According to FXStreet on Tuesday, 6 August, "This, in turn, is holding back traders from placing aggressive bullish bets around Crude Oil prices and keeping a lid on any meaningful appreciating move.", "Apart from this, subdued US Dollar (USD) price action, amid rising bets for a bigger interest rate cut by the Federal Reserve (Fed), turn out to be key factors acting as a tailwind for Crude Oil prices."

More news about Silver (SI).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com